Over the past few months, I’ve been paying close attention to what makes PDUFA Pulse most useful.
The clearest answer is: signal density.
So going forward, I’m planning to shift from two weekly editions to one stronger Monday issue focused on the names, dates, and risk changes that matter most.
My view is simple: for a PDUFA-focused product, more value comes from being selective and timely than from filling space just to maintain cadence.
That means the main weekly edition will stay tightly focused on:
upcoming PDUFA dates
meaningful changes in regulatory risk
major FDA developments that actually affect the setup
And when something truly material happens outside the regular schedule - an approval, CRL, hold, delay, label surprise, or other real change in the picture - I may still send an additional update.
I’m also working on a possible paid product for readers who want a more granular layer: things like sharper risk flags, evidence packs, and faster alerts when the setup changes.
That’s still taking shape, and I’m not assuming everyone wants it.
But if that sounds useful to you, just hit reply and say interested. That will help me gauge whether it’s worth building.
As always, thanks for reading.